News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Investment Banking

Glaxo deals provide BAML with $8.8bn merger bonanza

Wins are a boost for US bank, which has slipped in the European M&A rankings this year

Glaxo deals provide BAML with $8.8bn merger bonanza
Photo: Getty Images

Bank of America Merrill Lynch has landed advisory roles on two multibillion-dollar M&A transactions involving the pharmaceuticals giant GlaxoSmithKline — big wins for a bank that has struggled in the European deal tables this year.

BAML is working as the sole adviser to Angl0-Dutch consumer goods group Unilever on its €3.3bn ($3.7bn) purchase of GSK’s consumer nutrition business.

WSJ Logo